Eris Lifesciences stated that its consolidated net profit increased 12 per cent to Rs 101 crore for the third quarter ended December 2021.
The company stated that the revenue stood at Rs 332 crore in the third quarter of the current fiscal as against Rs 310 crore in the year-ago period, Eris Lifesciences said.
''Our focus on building leadership brands in fast-growing therapies coupled with several patent expiration opportunities will enable us to sustain our growth trajectory,'' stated Eris Lifesciences Chairman & Managing Director Amit Bakshi.
(With inputs from PTI)
West Bengal CM Mamata Banerjee Slams Amit Shah For SIR Ahead Of Elections
TRAI Blocks 21 Lakh Mobile Numbers, 1 Lakh Entities For Spam & Fraud
Mumbai News: 24-Year-Old Motorcyclist Killed After Being Hit By Water Tanker In Jogeshwari; Driver Arrested
Mumbai News: Husband Arrested For Allegedly Killing Wife After Violent Dispute In Borivali
